Literature DB >> 30615878

The CSD Drug Subset: The Changing Chemistry and Crystallography of Small Molecule Pharmaceuticals.

Mathew J Bryant1, Simon N Black2, Helen Blade2, Robert Docherty3, Andrew G P Maloney4, Stefan C Taylor2.   

Abstract

We report the generation and statistical analysis of the CSD drug subset: a subset of the Cambridge Structural Database (CSD) consisting of every published small-molecule crystal structure containing an approved drug molecule. By making use of InChI matching, a CSD Python API workflow to link CSD entries to the online database Drugbank.ca has been produced. This has resulted in a subset of 8632 crystal structures, representing all published solid forms of 785 unique drug molecules. We hope that this new resource will lead to improvements in targeted cheminformatics and statistical model building in a pharmaceutical setting. In addition to this, as part of the Advanced Digital Design of Pharmaceutical Therapeutics collaboration between academia and industry, we have been given the unique opportunity to run comparative analysis on the internal crystal structure databases of AstraZeneca and Pfizer, alongside comparison to the CSD as a whole.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords:  chemometrics; crystal structure(s); database(s); drug design; drug-like property(s)

Mesh:

Substances:

Year:  2019        PMID: 30615878     DOI: 10.1016/j.xphs.2018.12.011

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  New insights and innovation from a million crystal structures in the Cambridge Structural Database.

Authors:  Jason C Cole; Seth Wiggin; Francesca Stanzione
Journal:  Struct Dyn       Date:  2019-08-28       Impact factor: 2.920

2.  A Novel Rheological Method to Assess Drug-Polymer Interactions Regarding Miscibility and Crystallization of Drug in Amorphous Solid Dispersions for Oral Drug Delivery.

Authors:  Georgia Tsakiridou; Christos Reppas; Martin Kuentz; Lida Kalantzi
Journal:  Pharmaceutics       Date:  2019-11-22       Impact factor: 6.321

3.  Can molecular flexibility control crystallization? The case of para substituted benzoic acids.

Authors:  Sin Kim Tang; Roger J Davey; Pietro Sacchi; Aurora J Cruz-Cabeza
Journal:  Chem Sci       Date:  2020-11-16       Impact factor: 9.825

4.  Molecular, Solid-State and Surface Structures of the Conformational Polymorphic Forms of Ritonavir in Relation to their Physicochemical Properties.

Authors:  Chang Wang; Ian Rosbottom; Thomas D Turner; Sydney Laing; Andrew G P Maloney; Ahmad Y Sheikh; Robert Docherty; Qiuxiang Yin; Kevin J Roberts
Journal:  Pharm Res       Date:  2021-05-19       Impact factor: 4.200

5.  Overcoming the difficulties of predicting conformational polymorph energetics in molecular crystals via correlated wavefunction methods.

Authors:  Chandler Greenwell; Jessica L McKinley; Peiyu Zhang; Qun Zeng; Guangxu Sun; Bochen Li; Shuhao Wen; Gregory J O Beran
Journal:  Chem Sci       Date:  2020-01-14       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.